
Tazofirst 4000mg/500mg Injection
Marketer
Astemax Biotech Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazofirst 4000mg/500mg Injection
Combifirst 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by your physician based on illness severity. Strict adherence to prescribed usage is essential. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies or pre-existing kidney or liver conditions, as dosage adjustments or alternative medications may be necessary. Under medical guidance, this injection is generally considered safe during pregnancy and lactation.
Primary Ingredients of Tazofirst 4000mg/500mg Injection
There is no text provided to rephrase. Please provide the text you wish to have rewritten.
Uses of Tazofirst 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazofirst 4000mg/500mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazofirst 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazofirst 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazofirst 4000mg/500mg Injection works:
The injectable formulation Tazofirst, containing 4000mg of piperacillin and 500mg of tazobactam, employs a dual-acting mechanism. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Tazofirst 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Tazofirst (4000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazofirst, at a 4000mg/500mg dose, is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazofirst 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
The use of Tazofirst 4000mg/500mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Tazofirst 4000mg/500mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazofirst 4000mg/500mg Injection in patients with hepatic impairment appears to present a low risk. Existing evidence indicates dose modification of Tazofirst 4000mg/500mg Injection may be unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Tazofirst 4000mg/500mg Injection :
Omitting a scheduled dose of Tazofirst 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Tazofirst 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
